Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Vishal Madaan, Venkata Kolli, Durga P Bestha & Manan J Shah. (2013) Update on optimal use of lisdexamfetamine in the treatment of ADHD. Neuropsychiatric Disease and Treatment 9, pages 977-983.
Read now
Read now
Larry Culpepper & Ronna Fried. (2013) Attention-Deficit/Hyperactivity Disorder in a Chronic Care Paradigm. Postgraduate Medicine 125:4, pages 78-86.
Read now
Read now
Ann C Childress & Floyd R Sallee. (2012) The use of lisdexamfetamine dimesylate for the treatment of ADHD. Expert Review of Neurotherapeutics 12:1, pages 13-26.
Read now
Read now
Thomas E. Brown, Matthew Brams, Maria Gasior, Ben Adeyi, Thomas Babcock, Bryan Dirks, Brian Scheckner & Timothy Wigal. (2011) Clinical utility of ADHD symptom thresholds to assess normalization of executive function with lisdexamfetamine dimesylate treatment in adults. Current Medical Research and Opinion 27:sup2, pages 23-33.
Read now
Read now
Articles from other publishers (19)
Hedieh Arshiani, Valentin Artounian, Mahtab Motamed & Javad Alaghband-Rad. (2022) Psychometric Properties of the Persian Version of Brown Attention Deficit Disorder Scale (BADDS). Iranian Journal of Psychiatry and Behavioral Sciences 16:3.
Crossref
Crossref
Thomas E. Brown, Jie Chen & Brigitte Robertson. (2020) Improved Executive Function in Adults Diagnosed With Attention-Deficit/ Hyperactivity Disorder as Measured by the Brown Attention-Deficit Disorder Scale Following Treatment With SHP465 Mixed Amphetamine Salts Extended-Release: Post Hoc Analyses From 2 Randomized, Placebo-Controlled Studies. Journal of Attention Disorders 26:2, pages 256-266.
Crossref
Crossref
Greg W. Mattingly, Joshua Wilson, Leticia Ugarte & Paul Glaser. (2020) Individualization of attention-deficit/hyperactivity disorder treatment: pharmacotherapy considerations by age and co-occurring conditions. CNS Spectrums 26:3, pages 202-221.
Crossref
Crossref
Lisa WeyandtCaroline SweeneyLauren Thompson. (2020) The Effectiveness of Stimulant Medication at Improving Executive Functioning in Adults with ADHD. The ADHD Report 28:7, pages 1-8.
Crossref
Crossref
James Ermer, Patrick Martin, Mary Corcoran & Yumiko Matsuo. (2019) A phase 1, randomized, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects. Neuropsychopharmacology Reports 40:1, pages 16-29.
Crossref
Crossref
Kristi R. Griffiths, Jenny Yang, Stephen W. Touyz, Phillipa J. Hay, Simon D. Clarke, Mayuresh S. Korgaonkar, Linette Gomes, Gail Anderson, Sheryl Foster & Michael R. Kohn. (2019) Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol. Journal of Eating Disorders 7:1.
Crossref
Crossref
Evelina A. Zimovetz, Alain Joseph, Rajeev Ayyagari & Josephine A. Mauskopf. (2017) A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK. The European Journal of Health Economics 19:1, pages 21-35.
Crossref
Crossref
Andy Wolff, Revan Kumar Joshi, Jörgen Ekström, Doron Aframian, Anne Marie Lynge Pedersen, Gordon Proctor, Nagamani Narayana, Alessandro Villa, Ying Wai Sia, Ardita Aliko, Richard McGowan, Alexander Ross Kerr, Siri Beier Jensen, Arjan Vissink & Colin Dawes. (2016) A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI. Drugs in R&D 17:1, pages 1-28.
Crossref
Crossref
Jadwiga Najib, Dexter WimerJulie ZengKristina W LamNatalya RomanyakEva Paige MorganAnu Thadavila. (2017) Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. Journal of Central Nervous System Disease 9, pages 117957351772809.
Crossref
Crossref
A Villa, A Wolff, N Narayana, C Dawes, DJ Aframian, AM Lynge Pedersen, A Vissink, A Aliko, YW Sia, RK Joshi, R McGowan, SB Jensen, AR Kerr, J Ekström & G Proctor. (2016) World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction. Oral Diseases 22:5, pages 365-382.
Crossref
Crossref
C. Neill Epperson, Sheila Shanmugan, Deborah R. Kim, Sarah Mathews, Kathryn A. Czarkowski, Jeanette Bradley, Dina H. Appleby, Claudia Iannelli, Mary D. Sammel & Thomas E. Brown. (2015) New onset executive function difficulties at menopause: a possible role for lisdexamfetamine. Psychopharmacology 232:16, pages 3091-3100.
Crossref
Crossref
Diego L Rovaris, Nina R Mota, Bruna Santos da Silva, Pricila Girardi, Marcelo M Victor, Eugenio H Grevet, Claiton HD Bau & Verônica Contini. (2014) Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective. Pharmacogenomics 15:10, pages 1365-1381.
Crossref
Crossref
Patrick T. Martin, Mary Corcoran, Pinggao Zhang & Alain Katic. (2013) Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Effects of Lisdexamfetamine Dimesylate and Mixed Amphetamine Salts on Cognition Throughout the Day in Adults with Attention-Deficit/Hyperactivity Disorder. Clinical Drug Investigation 34:2, pages 147-157.
Crossref
Crossref
Lenard A Adler, Bryan Dirks, Patrick Deas, Aparna Raychaudhuri, Matthew Dauphin, Keith Saylor & Richard Weisler. (2013) Self-Reported quality of life in adults with attention-deficit/hyperactivity disorder and executive function impairment treated with lisdexamfetamine dimesylate: a randomized, double-blind, multicenter, placebo-controlled, parallel-group study. BMC Psychiatry 13:1.
Crossref
Crossref
Robert L. FindlingBen AdeyiBryan DirksThomas BabcockBrian SchecknerRobert LasserAnthony DeLeonLawrence D. Ginsberg. (2013) Parent-Reported Executive Function Behaviors and Clinician Ratings of Attention-Deficit/Hyperactivity Disorder Symptoms in Children Treated with Lisdexamfetamine Dimesylate. Journal of Child and Adolescent Psychopharmacology 23:1, pages 28-35.
Crossref
Crossref
Paul Hammerness. 2013. ADHD in Adults. ADHD in Adults
71
87
.
Christopher Steer, Jan Froelich, César A. Soutullo, Mats Johnson & Monica Shaw. (2012) Lisdexamfetamine Dimesylate. CNS Drugs 26:8, pages 691-705.
Crossref
Crossref
George J. DuPaul, Lisa L. Weyandt, Joseph S. Rossi, Brigid A. Vilardo, Sean M. O’Dell, Kristen M. Carson, Genevieve Verdi & Anthony Swentosky. (2011) Double-Blind, Placebo-Controlled, Crossover Study of the Efficacy and Safety of Lisdexamfetamine Dimesylate in College Students With ADHD. Journal of Attention Disorders 16:3, pages 202-220.
Crossref
Crossref
Paul G. Hammerness, Craig B. H. Surman & Ashley Chilton. (2011) Adult Attention-Deficit/Hyperactivity Disorder Treatment and Cardiovascular Implications. Current Psychiatry Reports 13:5, pages 357-363.
Crossref
Crossref